Aldosterone Synthase Inhibition With Lorundrostat for Uncont

This randomized clinical trial assesses the effect of 5 dosages of lorundrostat treatment vs placebo on 8-week systolic blood pressure change among adults with

Related Keywords

United States , Massachusetts , Boston , American , Catalys Pacific , Stevene Nissen , Novo Nordisk , Group Information , Gordy Health , Bristol Myers Squibb , Astrazeneca , Lucidact Health , Clinical Research , Boehringer Ingelheim , Mitsubishi , Novartis , Tanabe Pharmaceuticals , Medtronic , American Heart Association Hypertension Scientific Sessions , Johnson , Institute Inc , Amgen , Amsterdam Pharmaceuticals , Cleveland Clinic Coordinating Center , Between July , Patients With Uncontrolled Hypertension , Bend Points , Size Calculation , African American , End Point , Exploratory End Points , Biomarker End Points , Mitsubishi Tanabe Pharmaceuticals , Cleveland Clinic , Drs Laffin , Interest Disclosures , Crispr Therapeutics , Mineralys Therapeutics , Esperion Therapeutics , New Amsterdam Pharmaceuticals ,